U.S. Price for AIDS Drug: $20,000
March 24, 2003
Trimeris announced Thursday that the U.S. price for its new drug Fuzeon will be just under $20,000 for a year's supply. Fuzeon will cost more than twice as much as any other HIV drug, yet some AIDS activists had worried that the price might be even higher -- as much as $30,000 -- since drugs usually cost more in the United States than in other markets.Adapted from:
In other developments Thursday:
Trimeris spokesperson Robin Fastenau said that Trimeris and its partner Roche have set up an assistance program to help patients get third-party funding for Fuzeon, and there will also be a patient assistance program for low-income persons.
Even though North Carolina's ADAP has not decided to pay for Fuzeon, Evelyn Foust, head of the HIV/STD prevention and care branch of the state Division of Public Health, said the agency is advising AIDS physicians to write prescriptions for their patients as soon as possible to increase their chances of obtaining the drug -- and worry about finances later.
News & Observer (Raleigh, N.C.)
03.21.03; David Ranii
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.